MCM
MED icon

Matarin Capital Management’s Medifast MED Stock Holding History

Matarin Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,927
Closed -$412K – 298
2017
Q2 		$412K Sell
9,927
-31,933
-76% -$1.39M 0.04% 231
2017
Q1 		$1.86M Sell
41,860
-49,727
-54% -$2.14M 0.18% 167
2016
Q4 		$3.81M Sell
91,587
-18,657
-17% -$751K 0.43% 88
2016
Q3 		$4.17M Sell
110,244
-781
-0.7% -$28K 0.46% 102
2016
Q2 		$3.69M Buy
111,025
+3,709
+3% +$120K 0.5% 93
2016
Q1 		$3.24M Buy
107,316
+44,569
+71% +$1.3M 0.45% 97
2015
Q4 		$1.91M Sell
62,747
-8,322
-12% -$248K 0.29% 133
2015
Q3 		$1.91M Buy
71,069
+30,032
+73% +$875K 0.39% 90
2015
Q2 		$1.33M Buy
41,037
+4,222
+11% +$134K 0.38% 113
2015
Q1 		$1.1M Buy
36,815
+5,945
+19% +$189K 0.34% 127
2014
Q4 		$1.04M Buy
30,870
+919
+3% +$28.6K 0.45% 108
2014
Q3 		$983K Sell
29,951
-702
-2% -$21.5K 0.45% 110
2014
Q2 		$932K Buy
30,653
+4,651
+18% +$145K 0.42% 111
2014
Q1 		$756K Sell
26,002
-3,791
-13% -$102K 0.45% 83
2013
Q4 		$778K Buy
29,793
+7,235
+32% +$185K 0.48% 81
2013
Q3 		$607K Buy
22,558
+4,613
+26% +$123K 0.51% 81
2013
Q2 		$462K Buy
+17,945
New +$471K 0.47% 90

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Matarin Capital Management's MED Position: Q3 2017 in Review

Matarin Capital Management sold out of Medifast (MED) in Q3 2017, closing a stake of 9,927 shares — an estimated $412K sold.

Matarin Capital Management first reported a position in MED in Q2 2013 and held it in 17 quarters. The position peaked at $4.17M in Q3 2016. 168 funds tracked by Wall St. Rank hold MED as of Q3 2017.

  • Matarin Capital Management reported no remaining Medifast position as of Q3 2017 after selling out during the quarter.
  • Matarin Capital Management sold 9,927 Medifast shares in Q3 2017, an estimated $412K.
  • Matarin Capital Management first reported a position in Medifast in Q2 2013 and held it in 17 quarters.
  • Matarin Capital Management's Medifast position peaked at $4.17M in Q3 2016.
  • 168 funds tracked by Wall St. Rank held Medifast as of Q3 2017.

Based on Matarin Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.